Yanling Jin

机构：Roche (Canada), Yunnan University of Traditional Chinese Medicine · ORCID：0009-0004-6546-5201

发表论文 156 篇 · 总被引 1325 次 · h-index 19

代表论文

Overall Survival with Inavolisib in PIK3CA -Mutated Advanced Breast Cancer (2025 · New England Journal of Medicine · 被引 92)
Phase I/Ib Trial of Inavolisib Plus Palbociclib and Endocrine Therapy for PIK3CA -Mutated, Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced or Metastatic Breast Cancer (2024 · Journal of Clinical Oncology · 被引 38)
INAVO120: Phase III trial final overall survival (OS) analysis of first-line inavolisib (INAVO)/placebo (PBO) + palbociclib (PALBO) + fulvestrant (FULV) in patients (pts) with PIK3CA -mutated, hormone receptor-positive (HR+), HER2-negative (HER2–), endocrine-resistant advanced breast cancer (aBC). (2025 · Journal of Clinical Oncology · 被引 20)
Nickel cobalt sulfides and carbon nanotube intercalated graphene film electrodes for high-performance flexible all-solid-state asymmetric supercapacitors (2024 · Journal of Energy Storage · 被引 20)
Preparation of biomass-derived porous carbon aerogels via ice template-assisted chemical activation for high-performance supercapacitors (2024 · Journal of Analytical and Applied Pyrolysis · 被引 18)
Hydrangea-like NiMn layered double hydroxide grown on biomass-derived porous carbon as a high-performance supercapacitor electrode (2024 · Industrial Crops and Products · 被引 18)